Blanket Purchase Agreement GS23F0047U-VA25615A0078

This Federal Supply Schedule contract represents an interim agreement under General Services Administration (GSA) Schedule 65, Section I.B, authorizing Assertio Specialty Pharmaceuticals, LLC (UEI: K2H2NG62FC61) to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12). The contract was awarded on February 1, 2026, with an ultimate completion date of July 31, 2026, establishing a 18-month period of performance. This multiple award...

This Federal Supply Schedule award represents an interim agreement under General Services Administration Schedule 65, specifically addressing the procurement of drugs, pharmaceuticals, and hematology-related products. The contract was awarded on March 4, 2026, to Omeros Corporation (UEI: HM97JEC22LP2) as a multiple award vehicle with no set-aside utilization. The contract carries a ceiling value of $25,000 and is scheduled for completion by August 31, 2026. The Veterans Integrated Service...

Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, was awarded a single-award Indefinite Delivery Contract valued at $28.2 million by the Department of Veterans Affairs National Acquisition Center on June 7, 2021, for the supply of buprenorphine hydrochloride/naloxone hydrochloride sublingual tablets. The contract period of performance runs from June 7, 2021, through June 6, 2026, consisting of an initial one-year base period with four one-year option periods. This procurement...

This Blanket Purchase Agreement awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 provides first fill emergency prescription services. The single award BPA has a potential value of $3 million over five years from August 2023 to July 2028. R & M Reyes Enterprise, LLC is the prime contractor. The BPA enables 14 VA medical centers, community based outpatient clinics, and mobile medical units across Maine, New Hampshire, Vermont,...

This Federal Supply Schedule contract represents an interim agreement under General Services Administration (GSA) Schedule 65, section I.B, for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor, OWP Pharmaceuticals, Inc. (UEI: VTRCJWECEXV6), was awarded this multiple-award contract on February 1, 2026, with a contract ceiling value of $25,000.00 and an ultimate completion date of July 31, 2026. The contract was awarded without set-asides to the...

This Federal Supply Schedule contract, awarded on August 15, 2023, to Emergent Devices, Inc., provides the Department of Veterans Affairs (Veterans Integrated Service Network 12) with pharmaceutical products, drugs, and hematology-related items under General Services Administration (GSA) Schedule 65 IB. The contract carries an $11.8 million ceiling value and extends through August 14, 2028. Emergent Devices, a for-profit pharmaceutical manufacturer and subsidiary of Emergent BioSolutions,...

Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) holds a multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs, Veterans Integrated Service Network 12, valued at $216 million with a performance period extending through August 14, 2026. This indefinite delivery vehicle, awarded August 15, 2021, operates under the Pharmaceuticals and Drugs (FSS-61-IB) schedule and covers a broad portfolio of drugs, pharmaceuticals, and hematology-related...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a Blanket Purchase Agreement to Palisade Strategies LLC to provide Emergency Prescription Services. The BPA Call has a potential value of $500,000 and a period of performance from May 1, 2022 to April 30, 2023. As a Service-Disabled Veteran-Owned Small Business set-aside, the award will fulfill emergency prescription medication needs for veterans through Palisade Strategies'...

Horizon Therapeutics USA Inc. holds a Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) awarded by the Department of Veterans Affairs on August 15, 2019, with a ceiling value of $25.86 million and an ultimate completion date of September 30, 2025. This multiple-award contract vehicle enables the Veterans Health Administration (VHA) and its subordinate Veterans Integrated Service Networks (VISNs) to issue firm fixed-price delivery orders for specialty pharmaceutical...

The VA National Acquisition Center awarded a single-award Indefinite Delivery Contract to A-S Medication Solutions LLC (doing business as Allscripts Medication Services Group) on March 28, 2026, for the supply of Cefuroxime Axetil Tablets. This contract, valued at $940,366.32, supports multiple federal agencies including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract structure includes a one-year...